Progression of antiphospholipid antibody syndrome to catastrophic antiphospholipid antibody syndrome acutely with cessation of antithrombotic therapy

被引:5
|
作者
Katikireddi, V. S. [1 ]
Kandiah, D. A. [1 ,2 ]
机构
[1] Royal Brisbane & Womens Hosp, Dept Rheumatol, Brisbane, Qld 4029, Australia
[2] Univ Western Australia, Fac Med Dent & Hlth Sci, Perth, WA 6009, Australia
关键词
antiphospholipid antibody syndrome; catastrophic antiphospholipid antibody syndrome; antithrombotic therapy; warfarin; antiphospholipid antibody; INTERNATIONAL CONSENSUS STATEMENT; CLASSIFICATION CRITERIA; RECURRENT THROMBOSIS; PREVENTION; WARFARIN; ASPIRIN; UPDATE; TRIAL; DEATH; RISK;
D O I
10.1111/j.1445-5994.2012.02768.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Catastrophic antiphospholipid antibody syndrome (CAPS) is a serious condition that is often unrecognised with a high mortality. Cessation of anticoagulation in antiphospholipid antibody syndrome (APS) can have devastating consequences with progression to CAPS. Making a diagnosis of APS can however be challenging because of the evolving diagnostic criteria and difficulty in confirming thromboses. Management of these patients can also be complex, especially in those with coexistent thrombocytopenia. New potential treatments are emerging targeted on the immunomodulation of APS rather than just prevention of thrombosis. This article aims to highlight these diagnostic and management difficulties by reporting and discussing three cases of APS with progression to CAPS following cessation of anticoagulation, one with fatal consequences, with confirmation of CAPS on autopsy, and two with successful treatment and outcomes.
引用
收藏
页码:585 / 591
页数:7
相关论文
共 50 条
  • [1] Catastrophic antiphospholipid antibody syndrome as a first manifestation of primary antiphospholipid antibody syndrome in a middle-aged man
    Jafry, Nazrul Hassan
    Mubarak, Muhammed
    Ahmed, Ejaz
    Akhtar, Fazal
    CEN CASE REPORTS, 2020, 9 (02) : 152 - 158
  • [2] Antithrombotic Treatment in Antiphospholipid Syndrome: A Review
    Siniscalchi, Carmine
    Bernardi, Francesca Futura
    Di Micco, Pierpaolo
    Perrella, Alessandro
    Meschi, Tiziana
    Trama, Ugo
    IMMUNO, 2024, 4 (04): : 620 - 628
  • [3] Catastrophic antiphospholipid-antibody syndrome and danazol
    Roca, B
    Ferrer, D
    Calvo, B
    JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY, 2003, 13 (03) : 209 - 210
  • [4] Antiphospholipid antibody syndrome
    Bradley S. Jacobs
    Steven R. Levine
    Current Treatment Options in Neurology, 2000, 2 (5) : 449 - 457
  • [5] Antiphospholipid antibody syndrome
    Elena Cucurull
    Azzudin E. Gharavi
    Yamini Menon
    Wendell A. Wilson
    Current Treatment Options in Cardiovascular Medicine, 2003, 5 (2) : 127 - 136
  • [6] Antiphospholipid Antibody and Antiphospholipid Syndrome
    吴竞生
    血栓与止血学, 2008, 14 (06) : 243 - 245
  • [7] Antiphospholipid antibody syndrome and reproduction
    Kutteh, William H.
    CURRENT OPINION IN OBSTETRICS & GYNECOLOGY, 2014, 26 (04) : 260 - 265
  • [8] Catastrophic antiphospholipid antibody syndrome manifesting as an orbital ischemic syndrome
    Vaphiades, MS
    Brock, W
    Brown, HH
    Petursson, G
    Westfall, CT
    JOURNAL OF NEURO-OPHTHALMOLOGY, 2001, 21 (04) : 260 - 263
  • [9] Catastrophic antiphospholipid antibody syndrome in primary systemic sclerosis
    Kane, D
    McSweeney, F
    Swan, N
    Bresnihan, B
    JOURNAL OF RHEUMATOLOGY, 1998, 25 (04) : 810 - 812
  • [10] Catastrophic antiphospholipid antibody syndrome associated with ischaemic cardiomyopathy
    Pacella, Jonathan
    Rodriguez-Smith, Jackeline
    Kessler, Haeja
    Mantell, Benjamin S.
    CARDIOLOGY IN THE YOUNG, 2025,